A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

Breast cancer is a formidable foe that impacts the lives of countless women worldwide. Early detection is paramount in the fight against this disease, as it can significantly improve treatment ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Angelina Jolie has shockingly faced a torrent of callous online abuse after boldly baring the scars from her double ...

Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...

Mr. Sasse, a former senator from Nebraska, announced that he had received a diagnosis last week for Stage 4 pancreatic cancer ...

Use of MHT following menopause is not associated with an increased risk for breast cancer among BRCA1 and BRCA2 carriers.

Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...

Angelina Jolie shows mastectomy scars to spotlight breast health on TIME France. The Oscar-winning actor appears on the first ...

Another important cause is chronic pancreatitis. This means the pancreas is inflamed for a long time. It can happen because ...